# Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis

> **NCT04753034** · PHASE2 · COMPLETED · sponsor: **Teres Bio, Inc.** · enrollment: 63 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** TER-101
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT04753034
- **Lead sponsor:** Teres Bio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-18
- **Primary completion:** 2021-05-03
- **Final completion:** 2021-05-03
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2022-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04753034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04753034, "Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04753034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*